We continue to monitor COVID-19, flu and other respiratory viruses in our communities.
Read the most current information about prevention, testing and where to go if you're sick.
Inoperable patients with severe symptomatic aortic stenosis have survival rates as low as 50 percent within two years of symptom onset. A team of Washington University cardiac surgeons and interventional cardiologists at Barnes-Jewish Hospital has developed unique expertise in a new technology— percutaneous aortic valve replacement— that makes AVR an option for these highrisk patients.
Download the full pdf of Winter 2011